SELECTMD books three months net profit of $46.92 million

May 16, 2024

Sagicor Select Funds Limited Manufacturing & Distribution (SELECTMD) for the first quarter ended March 31, 2024, reported a 47% increase in interest income totalling $3.68 million compared to $2.50 million in the corresponding three months last year.

Dividend Income amounted to $28.42 million (2023: $27.54 million), representing an increase of 3% year over year.

Financial assets at fair value through P&L closed at a gain of $21.35 million (2023: Loss of $134.51 million).

Consequently, net investment income amounted to $53.45 million compared to net investment loss of $104.48 million for the first quarter ended March 31, 2023.

Administration expenses for the three months amounted to $6.54 million, a 2% decrease relative to $6.70 million reported in 2023.

No taxes were record in the period. As such, Net profit for the three months amounted to $46.92 million, up from net loss of $111.18 million reported in 2023.

Consequently, Earnings Per Share for the three months amounted to $0.01 (2023: LPS: $0.03). The twelve month trailing EPS was $0.09, and the number of shares used in these calculations was 3,816,612,000.

Notably, SELECTMD’s stock price closed the trading period on May 15, 2024, at a price of $0.70 with a corresponding P/E ratio of 7.65x.

Balance Sheet Highlights

The company’s assets totalled $4.15 billion (2023: $3.91 billion). The growth in total assets was mainly driven by a $236.50 million or 6% increase in ‘Financial assets at fair value through P&L’ to close at $3.96 billion (2023: $3.72 billion).

Shareholder’s equity was $4.13 billion (2023: $3.90 billion), representing a book value per share of $1.08 (2023: $1.02).


Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.